Metabolic Polymorphisms and Susceptibility to Cancer
International Agency for Research on Cancer (Publisher)
Published in July 1999
Book
Paperback/Softback
300 pages
978-92-832-2148-7 (ISBN)
Description
The study of interactions between genes and environmental exposures has expanded considerably in recent years. Highly penetrant genes that are involved in familial cancer have been identified, but are likely to account for a relatively small proportion of total cancers. Other predisposing genes have low penetrance, resulting in a moderate increase in the risk of specific cancers, but are widespread in the general population. This is the case for so-called metabolic polymorphisms. Scientific interest in metabolic polymorphisms is based on the possibility of identifying subgroups of the population which are at elevated risk of developing environmentally-induced cancer. However, such studies raise a series of problems that are methodological - related to the study design and analysis - and ethical - related to the practical use that can be made of genetic information. This volume deals thoroughly with such problems.
The book describes the polymorphism of genes encoding for enzymes involved in the metabolism of carcinogens or anti-carcinogens.
The book describes the polymorphism of genes encoding for enzymes involved in the metabolism of carcinogens or anti-carcinogens.
More details
Series
Language
English
Place of publication
Lyon
France
Target group
Professional and scholarly
Illustrations
bibliography
Dimensions
Height: 240 mm
Width: 170 mm
Weight
971 gr
ISBN-13
978-92-832-2148-7 (9789283221487)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Editor
Institut Municipal d'Investigacio Medica, Barcelona, Spain
Department of Pharmaceutical Biosciences, Uppsala University, Sweden
Sez. Epidemiologia, AREA, Turin, Italy
Genetic Epidemiology Branch, National Cancer Institute, Rockville, Maryland, USA
Department of Mathematics, Imperial Cancer Research Fund, London
International Agency for Research on Cancer, Lyon, France